Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.
about
The complexities of epidemiology and prevention of gastrointestinal cancersGenetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relativesThe genetic basis of Lynch syndrome and its implications for clinical practice and risk management.CLINICAL MANAGEMENT OF FAMILIES WITH HEREDITARY COLORECTAL CANCER SYNDROMES.Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.Screening and Health Behaviors among Persons Diagnosed with Familial Adenomatous Polyposis and Their Relatives.Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome.Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.Patient compliance based on genetic medicine: a literature review.Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project.How does genetic risk information for Lynch syndrome translate to risk management behaviours?A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.100 years Lynch syndrome: what have we learned about psychosocial issues?A mobile colonoscopic unit for lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country.Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency.Colonoscopy screening compliance and outcomes in patients with Lynch syndrome.Commentary on 'Colonoscopy screening compliance and outcomes in patients with Lynch syndrome'.Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French network.Molecular mechanisms of the preventable causes of cancer in the United StatesImpact of Chromoscopy on Adenoma Detection in Patients With Lynch Syndrome: A Prospective, Multicenter, Blinded, Tandem Colonoscopy Study
P2860
Q26865429-8233EF9C-EE8F-4509-BFB0-B57E9EF062EAQ31139897-0229FFEA-F265-45E0-8993-A3F3A0D16CE1Q34081267-9DB56555-D607-4364-95CD-579541C86BBAQ35087269-AB671458-C3F9-4D81-A11A-49ED1C672B3FQ35601519-6F2263FA-337B-4B15-91AA-80BDDCBEF88CQ36148182-1EC10100-86A7-4BA2-BF80-FA26CF89F3A6Q36392688-9BA0580A-6308-4E15-8D1A-E13A194EC98EQ37071737-94D044EF-36FA-46AB-9254-18EC05F3A18FQ37247972-A1B89DED-9C21-4255-B247-22F18AC7FCC3Q37323140-62092375-0B5B-4A3E-A899-2F76A82C0787Q37471829-BDB6229D-86AC-4299-84CE-B5B5C8A8E2CBQ37540290-AA8DF2D4-49A6-4435-ABE8-180307AF20ADQ37566105-91891F7E-FD9C-479E-A250-8A9AD551F392Q37686472-BC45CFB1-E053-43F6-BB46-7A754FD03279Q37710143-C5F1E628-7477-4FEB-9A60-AA36A9248F76Q38106642-98F6935B-8A80-4177-81A4-1B95081FD7C3Q38924281-29F0D607-B609-4973-90A0-5267C64F7B95Q39198359-CF5BB7CE-F16C-4CA7-8E82-7BB925A3CBB6Q43472310-6FFB7912-2D19-475F-B488-4374C27BDE9BQ46051976-59E4F483-7444-4D7A-AAC5-A13C08C33C1FQ48332941-04E5E746-CB2B-4455-9DEA-ECFB1416B672Q55139774-03537532-F5A3-4589-A6D1-3FFFBCD04B70Q56475873-68C7189C-4BF6-417B-B556-0D699EEC4F34Q58407928-F28939BD-82BA-4DD7-8D6F-27D68EAF25A1
P2860
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@ast
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@en
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@nl
type
label
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@ast
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@en
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@nl
prefLabel
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@ast
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@en
Prevalence and predictors of a ...... urveillance in Lynch syndrome.
@nl
P2093
P2860
P356
P1476
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome
@en
P2093
Daniel C Chung
Elena M Stoffel
Jonathan Terdiman
Kristen M Shannon
Mark Powell
Peggy Conrad
Rowena C Mercado
Sapna Syngal
Shilpa Grover
P2860
P304
P356
10.1038/AJG.2010.120
P407
P50
P577
2010-03-30T00:00:00Z